Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysis

Chiara Ciccarese, Roberto Iacovelli, Emilio Bria, Claudia Mosillo, Davide Bimbatti, Emanuela Fantinel, Iolanda Bisogno, Matteo Brunelli, Giampaolo Tortora

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences